Life Science Analytics' MedTRACK Introduces Phase III Report

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) March 17, 2004 -- (PRWEB) March 17 2004--Life Science Analytics' MedTRACK, a leading on-line research tool for Biomedical Intelligence, today introduced its "Phase III Report : A Strategic Assessment of Advanced Clinical Phase III" report. This report tracks the product pipeline in Advanced clinical trials for 250+ global biomedical companies by therapeutic indication and trial details, as well as the financial information of those companies that are publicly traded.





Table of Contents

Phase III Overview

Disease Specific analysis

Company Level analysis

Selected Financial Data

Key Products

Key Product Details

Description

Therapeutic Indication

Medical Specialty

Treatment Area

Trial Details

Milestones



The Products are listed in the following order:

Autoimmune and Inflammation

Blood and Lymphatic System

Cancer

Cardiovascular and Circulatory System

Central Nervous System

Dermatology

Digestive System

Infections

Kidneys and Genito-Urinary System

Metabolic/Endocrinology

Miscellaneous

Musculoskeletal Disorders

Ophthalmology and Optometry

Respiratory and Pulmonary System

Women's Health



Recent Phase III Updates

About MedTRACK Database and Reports



Number of pages: 200

Number of companies: 260 (184 US Public and 76 Global Private/Non US Public)

To purchase Phase III Report online, Please visit our Report center at http://www.medtrack.com/





About MedTRACK Database

MedTRACK is a fully integrated research and information resource that can track the product pipeline progression of nearly 4,500 global companies by therapeutic indication, product and trial details, as well as the financial information of those companies that are publicly traded. The database is designed to enable industry professionals to look at public and private companies that are working in a particular therapeutic area, core business focus and quickly determine where they rank clinically as well as financially. In addition, MedTRACK provides extensive research tools that allow you to customize your queries; select individualized search criteria, merge information on the financial statements and pipelines of two or more companies, and conduct searches of companies and their respective products by geography, mechanism of action, or by patent expiration.